ATLAS / Macro Radar / Reporting / GANX

Gain Therapeutics, Inc. (GANX) reporting calendar

Gain Therapeutics, Inc. files periodic reports with the SEC as GANX on Nasdaq. Atlas tracks 21 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
21

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open GANX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001104659-26-058649
10-K31 Dec 202526 Mar 202685 days0001104659-26-035188
10-Q30 Sep 202512 Nov 202543 days0001104659-25-110347
10-Q30 Jun 202512 Aug 202543 days0001558370-25-011220
10-Q31 Mar 202514 May 202544 days0001558370-25-007747
10-K31 Dec 202427 Mar 202586 days0001558370-25-003823
10-Q30 Sep 202414 Nov 202445 days0001558370-24-015709
10-Q30 Jun 20248 Aug 202439 days0001558370-24-011589
10-Q31 Mar 202414 May 202444 days0001558370-24-008132
10-K31 Dec 202326 Mar 202486 days0001558370-24-003943
10-Q30 Sep 202314 Nov 202345 days0001558370-23-019014
10-Q30 Jun 202310 Aug 202341 days0001558370-23-014499
10-Q31 Mar 202312 May 202342 days0001558370-23-009510
10-K31 Dec 202223 Mar 202382 days0001558370-23-004460
10-Q30 Sep 202210 Nov 202241 days0001558370-22-017414
10-Q30 Jun 20228 Aug 202239 days0001558370-22-012533
10-Q31 Mar 202216 May 202246 days0001558370-22-008968
10-K31 Dec 202125 Mar 202284 days0001558370-22-004363
10-Q30 Sep 202112 Nov 202143 days0001558370-21-015636
10-Q30 Jun 202112 Aug 202143 days0001558370-21-011445
10-Q31 Mar 202110 May 202140 days0001558370-21-006665

Source: SEC EDGAR company submissions for CIK 0001819411. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.